Pictet Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Hold
7,859
﹤0.01% 1940
2026
Q1
$224K Hold
7,859
﹤0.01% 1889
2025
Q4
$311K Hold
7,859
﹤0.01% 1690
2025
Q3
$277K Buy
7,859
+1,391
+22% +$47.9K ﹤0.01% 1694
2025
Q2
$212K Sell
6,468
-399
-6% -$13K ﹤0.01% 1798
2025
Q1
$222K Buy
6,867
+132
+2% +$4.9K ﹤0.01% 1753
2024
Q4
$206K Buy
+6,735
New +$217K ﹤0.01% 1845
2023
Q4
Sell
-5,325
Closed -$233K 1966
2023
Q3
$233K Buy
+5,325
New +$260K ﹤0.01% 1618

Other funds holding ATRC

Pictet Asset Management's ATRC Position: Q2 2026 in Review

Pictet Asset Management held its AtriCure (ATRC) position steady in Q2 2026 at 7,859 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Pictet Asset Management first reported a position in ATRC in Q3 2023 and has held it in 8 quarters since. The position peaked at $311K in Q4 2025. 84 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Pictet Asset Management held 7,859 shares of AtriCure worth $220K as of Q2 2026.
  • Pictet Asset Management left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1940 holding.
  • Pictet Asset Management first reported a position in AtriCure in Q3 2023 and has held it in 8 quarters since.
  • Pictet Asset Management's AtriCure position peaked at $311K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.